Looking deeply, thinking broadly

Prime Genomics is developing new biofluid-based molecular diagnostic tests that will make breast cancer detection more accurate, efficient, accessible and affordable for women anywhere.

Looking deeply, thinking broadly

Prime Genomics is developing new biofluid-based molecular diagnostic tests that will make breast cancer detection more accurate, efficient, accessible and affordable for women anywhere.

Prime Genomics’ noninvasive biofluid approach is:

Clearly different

IMPROVE DETECTION FOR
100%
OF WOMEN

Appropriate for all women, including
the ~50% with high density breasts
for whom imaging is inadequate.

Clearly needed

REDUCE
5.7M
CALL-BACKS EACH YEAR IN US

More precise detection eliminates
millions of follow-up appointments
and invasive procedures.

Clearly faster

COMPRESS
2-3
MONTH TIME FROM SCREEN TO DIAGNOSIS

Streamlines the multi-step process
and reduces false positives,
delays, and patient anxiety.

Clearly accessible

DRIVE TIMELY TESTING FOR
ALL
PATIENTS

True non-invasive testing increases
access and compliance, and helps
address current disparities in care.

Clinical Research Programs

Prime Genomics partners with leading clinicians, cancer care communities and imaging centers to validate our breakthrough cancer detection methods.

We are actively enrolling patients in studies to evaluate a non-invasive breast cancer detection test designed to benefit all women. This new test examines underlying molecular signals in cancer.

For physicians interested in learning more about participating in our Clinical Programs, please contact us at: clinical@primegenomics.com

This test is in development. It has not been evaluated by the FDA, and is not yet available for sale in the U.S.

Careers

Are you interested in working with a fast-paced genomic medicine startup creating breakthrough diagnostic tests for meaningful improvements to healthcare?

Join us and be the change that will make noninvasive, effective and precise cancer testing possible for millions of women in the US and billions of women globally.

Prime Genomics is looking for high-performing, team-oriented genomic and technology development scientists, data analysts, and biotechnology leaders.

See our open opportunities or contact us directly to learn more.

Careers

Are you interested in working with a fast-paced genomic medicine startup creating breakthrough diagnostic tests for meaningful improvements to healthcare?

Join us and be the change that will make noninvasive, effective and precise cancer testing possible for millions of women in the US and billions of women globally.

Prime Genomics is looking for high-performing, team-oriented genomic and technology development scientists, data analysts, and biotechnology leaders.

See our open opportunities or contact us directly to learn more.

Contact

Prime Genomics is an emerging precision healthcare company based in the heart of Silicon Valley, California. We are a team of accomplished innovators in molecular diagnostics, genomics, and advanced data science who believe that groundbreaking changes to healthcare are possible.

    Prime Genomics, Inc.

    319 N. Bernardo Avenue
    Mountain View, CA 94041
    See on map
    info@primegenomics.com